SCHEMBL5607277

SCHEMBL5607277

CCCCN1C(=O)C(Nc2ccc(CO)cc2)=C(c2ccccc2)S1(=O)=O.CCCCN1C(=O)C(Nc2ccc(N3CCN(Cc4ccccc4)CC3)cc2)=C(c2ccccc2)S1(=O)=O.CCCCN1C(=O)C(Nc2ccc(OC(F)(F)F)cc2)=C(c2ccccc2)S1(=O)=O.CCCCN1C(=O)C(Nc2ccc(OCc3ccccc3)cc2)=C(c2ccccc2)S1(=O)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 7/20 0.43
POLB P06746 1/20 0.41
CHRM2 P08172 4/20 0.40
CHRM1 P11229 2/20 0.40
CHRM5 P08912 1/20 0.40
CHRM3 P20309 1/20 0.40
RAB9A P51151 3/20 0.40
NPC1 O15118 2/20 0.40
TP53 P04637 1/20 0.40
LMNA P02545 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
FFAR1 O14842 1/20 0.39
MAPT P10636 2/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39
NR1H2 P55055 1/20 0.39
NR1H3 Q13133 1/20 0.39
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5613981 0.90 POLB (0.47) POLBRAB9ANPC1TP53LMNA
SCHEMBL3487587 0.83 NR1H2 (0.51) POLBL3MBTL1MAPTNR1H2NR1H3
SCHEMBL3486726 0.80 CA12 (0.41) TP53LMNASMN1; SMN2MAPTNR1H2
SCHEMBL3487073 0.80 AR (0.47) RAB9ANPC1SMN1; SMN2MAPTNR1H2
SCHEMBL3488251 0.76 CA12 (0.44) SMN1; SMN2MAPTNR1H2NR1H3ALDH1A1
SCHEMBL5606886 0.76 PLK1 (0.33) TP53MAPTNR1H2NR1H3ALDH1A1
SCHEMBL3487580 0.72 NR1H2 (0.54) POLBRAB9ANPC1SMN1; SMN2MAPT
SCHEMBL19128357 0.71 LTA4H (0.41) POLBCHRM5RAB9ANPC1MAPT
SCHEMBL5606877 0.69 NR1H2 (0.38) CHRM4POLBRAB9ANPC1SMN1; SMN2
SCHEMBL3488399 0.69 NR1H2 (0.55) POLBRAB9ANPC1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838686-A1 DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS AstraZeneca AB (SE) 2007-10-03 EP disclosed
WO-2006073363-A1 DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2006-07-13 WO disclosed